CC BY-NC-ND 4.0 · Journal of Fetal Medicine
DOI: 10.1055/s-0045-1806784
Case Report

Guillain Barré Syndrome in the First Trimester of Pregnancy after Tetanus Toxoid Immunization: A Rare Case Report and Review of Literature

1   Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Manu Goyal
1   Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Umme A. Sani
1   Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Pratibha Singh
1   Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
› Author Affiliations
Funding None.

Abstract

Guillain Barré syndrome (GBS) is a rare neurological entity that presents as rapidly progressive symmetrical ascending demyelinating polyneuropathy. Its incidence is infrequent during pregnancy at 1.2 to 1.9 cases per 100,000 population. It is associated with very high maternal mortality and pregnancy complications. Its management during pregnancy is challenging as delay in diagnosis occurs due to rarity and overlapping symptoms. We report a case of a 23 year old primigravida who presented at 3 months of gestation with rapidly progressive lower limb paralysis after tetanus toxoid immunization. She was managed by a multidisciplinary team with intensive care admission, ventilator support, and intravenous immunoglobulins. She showed improvement after 4 weeks and was discharged in a stable condition with little residual weakness in her lower limbs. On follow up, she achieved full recovery. The outcome of the pregnancy was vaginal birth of a male child with no postpartum relapse. GBS is a rare entity during pregnancy and has a high maternal mortality rate. Hence, it is important to have a strong clinical suspicion and aggressive treatment for favorable maternal and fetal outcomes.



Publication History

Article published online:
19 March 2025

© 2025. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sharma SR, Sharma N, Masaraf H, Singh SA. Guillain-Barré syndrome complicating pregnancy and correlation with maternal and fetal outcome in North Eastern India: a retrospective study. Ann Indian Acad Neurol 2015; 18 (02) 215-218
  • 2 Nelson LH, McLean Jr WT. Management of Landry-Guillain-Barré syndrome in pregnancy. Obstet Gynecol 1985; 65 (3, Suppl): 25S-29S
  • 3 Mori M, Kuwabara S, Yuki N. Fisher syndrome: clinical features, immunopathogenesis and management. Expert Rev Neurother 2012; 12 (01) 39-51
  • 4 Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol 2013; 12 (12) 1180-1188
  • 5 Pacheco LD, Saad AF, Hankins GD, Chiosi G, Saade G. Guillain-Barré syndrome in pregnancy. Obstet Gynecol 2016; 128 (05) 1105-1110